Bombay HC Orders FDA To Revoke Licence Suspensions After Deficiencies Rectified
Bombay HC directs FDA to revoke licence suspensions once deficiencies are rectified. The court flags serious consequences of inaction.

The Bombay High Court has directed the Food and Drugs Administration (FDA) to immediately revoke orders suspending or cancelling licences once an establishment rectifies deficiencies identified by authorities.
This decision was made by a bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad in an August 28 order. The court noticed several cases where establishments continued to face licence suspension or cancellation despite complying with the deficiencies.
The court was hearing a petition filed by Siddharth Agro, which procures, stores and supplies raw milk to large dairy processing units in Maharashtra. The FDA, Pune, suspended its licence on July 15 due to several deficiencies.
The state, represented by advocate Priyabhushan Kakade, said several deficiencies remained during a July 29 re-inspection. The petitioner sought another inspection to determine whether they had since been rectified. The High Court directed the FDA to conduct an inspection on August 31.
The judges said continued inaction could have serious consequences, including financial losses and affecting employees and the supply chain. The court described such litigation as “wholly avoidable” and said it unnecessarily burdened businesses and the judiciary.
In a similar case earlier, the court directed compensatory payment of Rs 5 lakh to a Pune dairy due to the FDA's inaction. The bench said an establishment that has cured the deficiencies cannot be penalised further due to the inaction of the respondents.
To prevent recurrence, the court directed that in all such cases, once the FDA is satisfied through an auto-generated report that deficiencies have been rectified, it must “forthwith revoke” the suspension or cancellation order.
In Siddharth Agro’s case, the July 15 suspension will automatically stand revoked once the compliance report is issued, subject to legal compliance. This decision is expected to bring relief to establishments that have rectified deficiencies but are still facing licence suspensions.
The court's order highlights the need for prompt action by regulatory authorities to avoid unnecessary litigation and burden on businesses. It also underscores the importance of ensuring that establishments are not penalised unfairly for deficiencies that have been rectified.
The decision is significant as it will impact various establishments in Maharashtra that are facing licence suspensions or cancellations due to deficiencies. The court's order will help to prevent unnecessary delays and ensure that businesses can operate smoothly once they have complied with regulatory requirements.
In conclusion, the Bombay High Court's decision is a welcome move to prevent unnecessary litigation and ensure that regulatory authorities take prompt action to revoke licence suspensions once deficiencies are rectified. This decision will have far-reaching implications for businesses in Maharashtra and will help to promote a fair and efficient regulatory environment.
The court's order is also a reminder of the importance of ensuring that regulatory authorities are held accountable for their actions and that businesses are not unfairly penalised for deficiencies that have been rectified. The decision is expected to bring relief to establishments that have been facing licence suspensions or cancellations due to deficiencies and will help to promote a positive business environment in Maharashtra.
Overall, the Bombay High Court's decision is a significant step towards promoting a fair and efficient regulatory environment in Maharashtra. It highlights the need for prompt action by regulatory authorities and ensures that businesses are not unfairly penalised for deficiencies that have been rectified.
This decision will have a positive impact on the business community in Maharashtra and will help to promote economic growth and development in the state. The court's order is a welcome move towards creating a favorable business environment and will help to attract investments and promote economic activity in the state.
In the long run, the decision is expected to have a positive impact on the economy of Maharashtra and will help to promote sustainable growth and development. The court's order is a significant step towards creating a fair and efficient regulatory environment and will help to ensure that businesses operate smoothly and efficiently in the state.
The decision is also expected to have a positive impact on the employment sector in Maharashtra. By promoting a favorable business environment, the court's order will help to create new job opportunities and will help to promote economic growth and development in the state.
In conclusion, the Bombay High Court's decision is a significant step towards promoting a fair and efficient regulatory environment in Maharashtra. It highlights the need for prompt action by regulatory authorities and ensures that businesses are not unfairly penalised for deficiencies that have been rectified. The decision is expected to have a positive impact on the business community in Maharashtra and will help to promote economic growth and development in the state.
Frequently asked questions
What did the Bombay High Court direct the FDA to do?
The Bombay High Court directed the FDA to forthwith revoke orders suspending or cancelling licences once an establishment rectifies deficiencies identified by authorities.
What are the consequences of the FDA's inaction?
The consequences of the FDA's inaction include financial losses and affecting employees and the supply chain.